WallStreetZenWallStreetZen

NASDAQ: HTGM
Htg Molecular Diagnostics Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for HTGM

Based on 2 analysts offering 12 month price targets for Htg Molecular Diagnostics Inc.
Min Forecast
$2.00+254.61%
Avg Forecast
$2.50+343.26%
Max Forecast
$3.00+431.91%

Should I buy or sell HTGM stock?

Based on 2 analysts offering ratings for Htg Molecular Diagnostics Inc.
Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their HTGM stock forecasts and price targets.

HTGM stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Top 5%
96
BuyMaintains$2.00+254.61%2022-08-15
Craig-Hallum
Bottom 2%
2
BuyMaintains$3.00+431.91%2022-03-30

1 of 1

Forecast return on equity

Is HTGM forecast to generate an efficient return?
Company
-168.61%
Industry
467.49%
Market
100.32%
HTGM's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is HTGM forecast to generate an efficient return on assets?
Company
-42.29%
Industry
9.76%
HTGM is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

HTGM earnings per share forecast

What is HTGM's earnings per share in the next 2 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$2.08
Avg 2 year Forecast
-$0.85

HTGM revenue forecast

What is HTGM's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$7.9M-1.78%
Avg 2 year Forecast
$14.9M+83.93%
HTGM's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

HTGM revenue growth forecast

How is HTGM forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
-1.78%
Industry
-0.13%
Market
15.15%
HTGM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
HTGM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

HTGM vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
HTGM$0.56$2.50+343.26%Buy
MOTS$1.88$11.00+485.11%Buy
SQL$0.74$3.00+307.61%Strong Buy
CEMI$0.42N/AN/AHold
OPGN$0.28$3.00+971.43%Buy

Htg Molecular Diagnostics Stock Forecast FAQ

Is Htg Molecular Diagnostics Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: HTGM) stock is to Buy HTGM stock.

Out of 2 analysts, 0 (0%) are recommending HTGM as a Strong Buy, 2 (100%) are recommending HTGM as a Buy, 0 (0%) are recommending HTGM as a Hold, 0 (0%) are recommending HTGM as a Sell, and 0 (0%) are recommending HTGM as a Strong Sell.

If you're new to stock investing, here's how to buy Htg Molecular Diagnostics stock.

What is HTGM's earnings growth forecast for 2022-2023?

(NASDAQ: HTGM) Htg Molecular Diagnostics's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 25.59%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 52.44%.

Htg Molecular Diagnostics's earnings in 2022 is -$22,067,639.On average, 2 Wall Street analysts forecast HTGM's earnings for 2022 to be -$22,980,071, with the lowest HTGM earnings forecast at -$22,980,071, and the highest HTGM earnings forecast at -$22,980,071.

In 2023, HTGM is forecast to generate -$9,390,894 in earnings, with the lowest earnings forecast at -$9,611,857 and the highest earnings forecast at -$9,169,932.

What is HTGM's revenue growth forecast for 2022-2023?

(NASDAQ: HTGM) Htg Molecular Diagnostics's forecast annual revenue growth rate of -1.78% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of -0.13%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.15%.

Htg Molecular Diagnostics's revenue in 2022 is $8,073,514.On average, 1 Wall Street analysts forecast HTGM's revenue for 2022 to be $87,611,520, with the lowest HTGM revenue forecast at $87,611,520, and the highest HTGM revenue forecast at $87,611,520.

In 2023, HTGM is forecast to generate $164,064,448 in revenue, with the lowest revenue forecast at $164,064,448 and the highest revenue forecast at $164,064,448.

What is HTGM's forecast return on assets (ROA) for 2022-2023?

(NASDAQ: HTGM) forecast ROA is -42.29%, which is lower than the forecast US Diagnostics & Research industry average of 9.76%.

What is HTGM's Price Target?

According to 2 Wall Street analysts that have issued a 1 year HTGM price target, the average HTGM price target is $2.50, with the highest HTGM stock price forecast at $3.00 and the lowest HTGM stock price forecast at $2.00.

On average, Wall Street analysts predict that Htg Molecular Diagnostics's share price could reach $2.50 by Aug 15, 2023. The average Htg Molecular Diagnostics stock price prediction forecasts a potential upside of 343.26% from the current HTGM share price of $0.56.

What is HTGM's Earnings Per Share (EPS) forecast for 2022-2023?

(NASDAQ: HTGM) Htg Molecular Diagnostics's current Earnings Per Share (EPS) is -$2.64. On average, analysts forecast that HTGM's EPS will be -$2.08 for 2022, with the lowest EPS forecast at -$2.08, and the highest EPS forecast at -$2.08. In 2023, HTGM's EPS is forecast to hit -$0.85 (min: -$0.87, max: -$0.83).

What is HTGM's forecast return on equity (ROE) for 2022-2023?

(NASDAQ: HTGM) forecast ROE is -168.61%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.